EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A low pre-existing anti-NS1 humoral immunity to DENV is associated with microcephaly development after gestational ZIKV exposure

Sebastián Castro-Trujillo, William R Mejía, Katherine Segura, Juanita Castro-Meneses, Rocío Vega, Doris Salgado, Carlos E Fonseca, Ángela M Ortiz, Federico Perdomo-Celis, Irene Bosch, Carlos F Narváez iD

PLOS Neglected Tropical Diseases · 06.01.2025 · 19 (1) · e0012193

DOI: 10.1371/journal.pntd.0012193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 06.01.2025. Verfasst von Sebastián Castro-Trujillo und 10 weiteren Autor:innen. Beteiligte Einrichtung: División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia. Hauptthemen laut MEDLINE: Zika Virus Infection, Microcephaly, Antibodies, Viral, Zika Virus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Surcolombiana, MIT Solve, Sistema General de Regalías de Colombia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gestational Zika virus (ZIKV) infection is associated with the development of congenital Zika syndrome (CZS), which includes microcephaly and fetal demise. The magnitude and quality of orthoflavivirus-specific humoral immunity have been previously linked to the development of CZS. However, the role of ZIKV NS1-specific humoral immunity in mothers and children with prenatal ZIKV exposure and CZS remains undefined. In addition, considering that most of the at-risk population lives in dengue virus (DENV)-endemic areas, it is not clear what is the association between pre-existing DENV NS1-specific humoral immunity and CZS.

Methods

Here, we studied 328 mothers and children with a clinical diagnosis and seropositivity for ZIKV infection during pregnancy, included during the 2015–2016 ZIKV epidemic in Colombia. We also performed clinical evaluation and pediatric neurological follow-up. The relative levels of circulating NS1-specific IgM and IgG against ZIKV and DENV were evaluated in mothers and children, and the association with the development of microcephaly was analyzed.

Results

DENV and ZIKV IgG-NS1 antibodies in pregnant women were placentally transferred, and this passage and its duration in children depended on the maternal levels of the antibodies. We reported that higher concentrations of pre-existing DENV, but not ZIKV IgG-NS1 antibodies, were associated with a reduced risk of CZS-related microcephaly. Also, we observed that the IgM-NS1 response in infants is long-term and has a minor association with poor outcomes.

Conclusions

The development of microcephaly in children prenatally exposed to ZIKV is associated with low plasma levels of placentally transferred, pre-existing DENV IgG-NS1 antibodies. These data are compatible with a protective role of anti-NS1 IgG antibodies against ZIKV infection during pregnancy and highlight the promising role of NS1 as an orthoflavivirus vaccine target in high-risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika Virus InfectionMicrocephalyAntibodies, ViralZika VirusViral Nonstructural ProteinsImmunity, HumoralDengue VirusImmunoglobulin MImmunoglobulin GPregnancy Complications, InfectiousHumansFemalePregnancyAdultMaleColombiaYoung AdultInfantChild, PreschoolAdolescent

Substanzen

Antibodies, ViralViral Nonstructural ProteinsImmunoglobulin MImmunoglobulin GNS1 protein, zika virus

Autor:innen und Institutionen

  • División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia.
  • Área de Pediatría, Departamento de Ciencias Clínicas, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia.
  • Servicio de Pediatría, Hospital Universitario de Neiva, Neiva, Huila, Colombia.
  • Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Programa de Biología Aplicada, Facultad de Ciencias Exactas y Naturales, Universidad Surcolombiana, Neiva, Huila, Colombia.
  • Institute for Medical Engineering and Science, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, United States of America.

ORCID-Profile: Carlos F Narváez

Förderung

  • Universidad Surcolombiana
  • MIT Solve
  • Sistema General de Regalías de Colombia

Zitieren

APA

Castro-Trujillo, S., Mejía, W. R., Segura, K., Castro-Meneses, J., Vega, R., Salgado, D., Fonseca, C. E., Ortiz, Á. M., Perdomo-Celis, F., Bosch, I., & Narváez, C. F. (2025). A low pre-existing anti-NS1 humoral immunity to DENV is associated with microcephaly development after gestational ZIKV exposure. PLOS Neglected Tropical Diseases, 19(1), e0012193. https://doi.org/10.1371/journal.pntd.0012193

Vancouver

Castro-Trujillo S, Mejía WR, Segura K, Castro-Meneses J, Vega R, Salgado D, et al. A low pre-existing anti-NS1 humoral immunity to DENV is associated with microcephaly development after gestational ZIKV exposure. PLOS Neglected Tropical Diseases. 2025;19(1):e0012193. doi:10.1371/journal.pntd.0012193

BibTeX
@article{CastroTrujillo2025,
  author = {Castro-Trujillo, Sebastián and Mejía, William R and Segura, Katherine and Castro-Meneses, Juanita and Vega, Rocío and Salgado, Doris and Fonseca, Carlos E and Ortiz, Ángela M and Perdomo-Celis, Federico and Bosch, Irene and Narváez, Carlos F},
  title = {A low pre-existing anti-NS1 humoral immunity to DENV is associated with microcephaly development after gestational ZIKV exposure},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  volume = {19},
  number = {1},
  pages = {e0012193},
  doi = {10.1371/journal.pntd.0012193}
}
Kostenlos starten →